BACKGROUND: Despite overwhelming evidence that major depression is highly heritable, recent studies have localized only a single depression-related locus reaching genome-wide significance and have yet to identify a causal gene. Focusing on family-based studies of quantitative intermediate phenotypes or endophenotypes, in tandem with studies of unrelated individuals using categorical diagnoses, should improve the likelihood of identifying major depression genes. However, there is currently no empirically derived statistically rigorous method for selecting optimal endophentypes for mental illnesses. Here, we describe the endophenotype ranking value, a new objective index of the genetic utility of endophenotypes for any heritable illness. METHODS: Applying endophenotype ranking value analysis to a high-dimensional set of over 11,000 traits drawn from behavioral/neurocognitive, neuroanatomic, and transcriptomic phenotypic domains, we identified a set of objective endophenotypes for recurrent major depression in a sample of Mexican American individuals (n = 1122) from large randomly selected extended pedigrees. RESULTS: Top-ranked endophenotypes included the Beck Depression Inventory, bilateral ventral diencephalon volume, and expression levels of the RNF123 transcript. To illustrate the utility of endophentypes in this context, each of these traits were utlized along with disease status in bivariate linkage analysis. A genome-wide significant quantitative trait locus was localized on chromsome 4p15 (logarithm of odds = 3.5) exhibiting pleiotropic effects on both the endophenotype (lymphocyte-derived expression levels of the RNF123 gene) and disease risk. CONCLUSIONS: The wider use of quantitative endophenotypes, combined with unbiased methods for selecting among these measures, should spur new insights into the biological mechanisms that influence mental illnesses like major depression.
BACKGROUND: Despite overwhelming evidence that major depression is highly heritable, recent studies have localized only a single depression-related locus reaching genome-wide significance and have yet to identify a causal gene. Focusing on family-based studies of quantitative intermediate phenotypes or endophenotypes, in tandem with studies of unrelated individuals using categorical diagnoses, should improve the likelihood of identifying major depression genes. However, there is currently no empirically derived statistically rigorous method for selecting optimal endophentypes for mental illnesses. Here, we describe the endophenotype ranking value, a new objective index of the genetic utility of endophenotypes for any heritable illness. METHODS: Applying endophenotype ranking value analysis to a high-dimensional set of over 11,000 traits drawn from behavioral/neurocognitive, neuroanatomic, and transcriptomic phenotypic domains, we identified a set of objective endophenotypes for recurrent major depression in a sample of Mexican American individuals (n = 1122) from large randomly selected extended pedigrees. RESULTS: Top-ranked endophenotypes included the Beck Depression Inventory, bilateral ventral diencephalon volume, and expression levels of the RNF123 transcript. To illustrate the utility of endophentypes in this context, each of these traits were utlized along with disease status in bivariate linkage analysis. A genome-wide significant quantitative trait locus was localized on chromsome 4p15 (logarithm of odds = 3.5) exhibiting pleiotropic effects on both the endophenotype (lymphocyte-derived expression levels of the RNF123 gene) and disease risk. CONCLUSIONS: The wider use of quantitative endophenotypes, combined with unbiased methods for selecting among these measures, should spur new insights into the biological mechanisms that influence mental illnesses like major depression.
Authors: Augustine Kong; Daniel F Gudbjartsson; Jesus Sainz; Gudrun M Jonsdottir; Sigurjon A Gudjonsson; Bjorgvin Richardsson; Sigrun Sigurdardottir; John Barnard; Bjorn Hallbeck; Gisli Masson; Adam Shlien; Stefan T Palsson; Michael L Frigge; Thorgeir E Thorgeirsson; Jeffrey R Gulcher; Kari Stefansson Journal: Nat Genet Date: 2002-06-10 Impact factor: 38.330
Authors: G Nishioka; M Yamada; K Kudo; K Takahashi; Y Kiuchi; T Higuchi; K Momose; K Kamijima; M Yamada Journal: J Neural Transm (Vienna) Date: 2003-03 Impact factor: 3.575
Authors: Kathleen R Merikangas; Aravinda Chakravarti; Steven O Moldin; Houmam Araj; John C Blangero; Margit Burmeister; John Crabbe; J Raymond Depaulo; Edward Foulks; Nelson B Freimer; Doreen S Koretz; William Lichtenstein; Emmanuel Mignot; Allan L Reiss; Neil J Risch; Joseph S Takahashi Journal: Biol Psychiatry Date: 2002-09-15 Impact factor: 13.382
Authors: Eric J Nestler; Michel Barrot; Ralph J DiLeone; Amelia J Eisch; Stephen J Gold; Lisa M Monteggia Journal: Neuron Date: 2002-03-28 Impact factor: 17.173
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Samuel R Mathias; Emma E M Knowles; Jack W Kent; D Reese McKay; Joanne E Curran; Marcio A A de Almeida; Thomas D Dyer; Harald H H Göring; Rene L Olvera; Ravi Duggirala; Peter T Fox; Laura Almasy; John Blangero; David C Glahn Journal: Hum Brain Mapp Date: 2015-10-20 Impact factor: 5.038
Authors: Susan Wright; Peter Kochunov; Joshua Chiappelli; Robert McMahon; Florian Muellerklein; S Andrea Wijtenburg; Michael G White; Laura M Rowland; L Elliot Hong Journal: Neurobiol Aging Date: 2014-02-28 Impact factor: 4.673
Authors: K R Merikangas; L Cui; L Heaton; E Nakamura; C Roca; J Ding; H Qin; W Guo; Y Y Shugart; Y Yao-Shugart; C Zarate; J Angst Journal: Mol Psychiatry Date: 2013-10-15 Impact factor: 15.992
Authors: U Dannlowski; H J Grabe; K Wittfeld; J Klaus; C Konrad; D Grotegerd; R Redlich; T Suslow; N Opel; P Ohrmann; J Bauer; P Zwanzger; I Laeger; C Hohoff; V Arolt; W Heindel; M Deppe; K Domschke; K Hegenscheid; H Völzke; D Stacey; H Meyer Zu Schwabedissen; H Kugel; B T Baune Journal: Mol Psychiatry Date: 2014-04-29 Impact factor: 15.992
Authors: Heather C Whalley; Emma Sprooten; Suzanna Hackett; Lynsey Hall; Douglas H Blackwood; David C Glahn; Mark Bastin; Jeremy Hall; Stephen M Lawrie; Jessika E Sussmann; Andrew M McIntosh Journal: Biol Psychiatry Date: 2013-02-28 Impact factor: 13.382
Authors: David C Glahn; Emma E M Knowles; D Reese McKay; Emma Sprooten; Henriette Raventós; John Blangero; Irving I Gottesman; Laura Almasy Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2014-01-24 Impact factor: 3.568
Authors: Emma E M Knowles; Jack W Kent; D Reese McKay; Emma Sprooten; Samuel R Mathias; Joanne E Curran; Melanie A Carless; Marcio A A de Almeida; H H Goring Harald; Tom D Dyer; Rene L Olvera; Peter T Fox; Ravi Duggirala; Laura Almasy; John Blangero; David C Glahn Journal: J Affect Disord Date: 2015-11-17 Impact factor: 4.839